Shanghai Bio-Forum Focuses On Patent Protection And Drug Pricing
This article was originally published in PharmAsia News
Executive Summary
Patent protection and drug pricing were hot issues at the recent Conference of Chinese Biopharmaceutical Association and Shanghai Bio-Forum. Delegates agreed that patent protection is a prerequisite of collaboration and represents a key factor that is irreplaceable in the trend of global cooperation. China's laws and regulations on patent and intellectual property protection are well-received but overseas investors and partners expressed concern on the effectiveness of their long-term implementation. Opportunities for collaboration abound in the biopharmaceutical process and China offers the common language of an internationally recognized GMP system. (Click here for more - Chinese Language)